Gender-Related Response of Body Systems in COVID-19 Affects Outcome

Gender-Related Response of Body Systems in COVID-19 Affects Outcome

Severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2) is the seventh member of the coronaviruses (CoVs) family that infects humans and causes coronavirus disease 2019 (COVID-19), which is currently a global pandemic. Widespread secretion of cytokines has been shown to occur early in...

Full description

Bibliographic Details
Main Authors:	M. Khaksari, N. Sabet, Z. Soltani, H. Bashiri
Format:	Article
Language:	Russian
Published:	Sankt-Peterburg : NIIÈM imeni Pastera 2019-06-01
Series:	Infekciâ i Immunitet
Subjects:	coronavirus disease 2019, gender difference, inflammation, angiotensin-converting enzyme 2, estrogen, progesterone
Online Access:	https://www.iimmun.ru/iimm/article/view/1664

Similar Items

Vitamin D and Sex Differences in COVID-19
by: Maria Teresa Pagano, et al.
Published: (2020-09-01)

Strategies and Advances in Combating COVID-19 in China
by: Wei Liu, et al.
Published: (2020-10-01)

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01)

Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19
by: Eli Mansour, et al.
Published: (2021-02-01)

Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
by: Xiao-Ce Dai, et al.
Published: (2021-04-01)

Paying Attention to Circadian Rhythms in the Treatment of COVID-19
by: Atefeh Bakhtazad, et al.
Published: (2020-04-01)

Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality
by: Malindu E. Fernando, et al.
Published: (2021-09-01)

Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis
by: Zhidan Yu, et al.
Published: (2021-07-01)

COVID-19 outcomes in postmenopausal and perimenopausal females: Is estrogen hormone attributing to gender differences?
by: Ruchika Garg, et al.
Published: (2020-01-01)

Herbal medicines in the treatment of coronavirus disease 2019 (COVID-19)
by: Audrey Tolouian, et al.
Published: (2021-05-01)

Potential adverse effects of coronavirus disease 2019 on the cardiovascular system
by: Bing-Yin Wang, et al.
Published: (2021-01-01)

NOX-Dependent Signaling Dysregulation in Severe COVID-19: Clues to Effective Treatments
by: Simona Damiano, et al.
Published: (2020-12-01)

Exploring the causes of mild COVID-19 involvement in pediatric patients
by: A. Naserghandi, et al.
Published: (2020-09-01)

Gender Difference in Chronic Cough: Are Women More Likely to Cough?
by: Haodong Bai, et al.
Published: (2021-05-01)

Is diet partly responsible for differences in COVID-19 death rates between and within countries?
by: Jean Bousquet, et al.
Published: (2020-05-01)

Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran
by: S. Mirmohammadi, et al.
Published: (2020-11-01)

Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database
by: Zhonglin Li, et al.
Published: (2020-10-01)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
by: Si-Hyuck Kang, et al.
Published: (2021-06-01)

A mini-review on the impact of COVID 19 on vital organs
by: Muhammad Dawood Shah, et al.
Published: (2021-11-01)

Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
by: Yu-Huang Liao, et al.
Published: (2020-12-01)

Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension
by: Jinwoo Lee, et al.
Published: (2021-03-01)

Clinical Profile of COVID-19 in Children and Research Progress on Angiotensin-converting Enzyme 2: A Mini-review
by: Qian Gao, et al.
Published: (2020-10-01)

Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients
by: Nayara Azinheira Nobrega Cruz, et al.
Published: (2021-08-01)

COVID-19: a hypothesis regarding the ventilation-perfusion mismatch
by: Mario G. Santamarina, et al.
Published: (2020-07-01)

Exploring the Demographics and Clinical Characteristics Related to the Expression of Angiotensin-Converting Enzyme 2, a Receptor of SARS-CoV-2
by: Shengjie Li, et al.
Published: (2020-08-01)

COVID-19 and Heart: From Clinical Features to Pharmacological Implications
by: Vincenzo Russo, et al.
Published: (2020-06-01)

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
by: Philip Braude, et al.
Published: (2020-12-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-06-01)

Inverse association between hypertension treatment and COVID-19 prevalence in Japan
by: Masako Kinoshita, et al.
Published: (2021-07-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

Pathophysiological mechanisms of coronavirus disease (COVID-19) progression and fatal complications in patients with diabetes
by: T. O. Briukhanova, et al.
Published: (2020-10-01)

Mesenchymal stem cell infusion as a promising therapeutic approach to treat coronavirus disease 2019 patients
by: Nihal AlMuraikhi
Published: (2020-01-01)

A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
by: Amanj Kurdi, et al.
Published: (2020-12-01)

Association between COVID-19 and cardiovascular disease
by: Kamna Srivastava, Ph.D
Published: (2020-08-01)

Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019
by: Mudasir S. Andrabi, et al.
Published: (2020-11-01)

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
by: Chunsheng Zhu, et al.
Published: (2020-08-01)

Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
by: Omonike A. Olaleye, et al.
Published: (2021-03-01)

The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
by: Francesca Silvagno, et al.
Published: (2020-07-01)

Gender aspects of the pain syndrome
by: K O Ostrovska
Published: (2019-04-01)

COVID-19: What Iodine Maps From Perfusion CT can reveal—A Prospective Cohort Study
by: Mario G. Santamarina, et al.
Published: (2020-10-01)